Greiner Bio-One webinars
Greiner Bio-One offers educational webinars for both BioScience and Preanalytics customers several times throughout the year at no charge to industry professionals. These webinars are recorded and made available to customers to enjoy in the future.
Please note that recordings for Preanalytics webinars are available for a maximum of 7 days after the live event due to the requests of our speakers. When available, these recordings will be listed here.
Magnetic 3D Cell Culture: Tools to Bridge the Gap Between 2D and 3D
The growing push for 3D cell culture models is limited by technical challenges in handling, processing, and scalability to high-throughput applications. To meet these challenges, Greiner Bio-One offers an innovative technology called magnetic 3D bioprinting, in which cells are individually magnetized and assembled with magnetic forces without changing the phenotype or the physiology of these cells. Magnetization of cells not only makes routine cell culture and experiments feasible and scalable, but also enables scientist to have fine spatial control in the formation of spheroids or more complex structures.
This presentation will focus on recent developments using magnetic 3D bioprinting, particularly in cancer biology and immunology. Specifically, it will demonstrate a method for phenotypic profiling of cell types within spheroids using real-time high-throughput imaging.
- General technique of magnetic 3D cell culture and magnetic 3D bioprinting
- Key advantages of 3D cell culture over other techniques
- Broad applications of 3D cell culture
- Applications in immunobiology
- Comparison between magnetic 3D cell culture and in vivo results in collaboration with MD Anderson Cancer Center
20. October 2020, 15:30, MEST
Glauco R. Souza, PhD Director of Global Business Developement and Innovation - Greiner Bio-One
Good Practice in Biobanking - A Labware Manufacturer's Perspective
More than ever we see an increasing demand for high-quality and high-throughput libraries of biological and chemical specimens. Reasons for this trend are diverse and range from ground-breaking developments in personalised medicine over new trends in compound screening to the enormously high throughput of patient samples in COVID-19 testing.
- Good practices in sample storage and their link to labware
- Types of storage containers and their intended applications
- Options for sample tracking – how to utilise them optimally
- Pre-requisites and prospects of process automation
- Quality certificates for labware
16. October 2020, 11:00, BST
Sven Muehlfriedel - Greiner Bio-One Product Management
Preventing Specimen Rejection in the Collection of Non-Blood Samples
During the course of this 60 minute, P.A.C.E.® accredited webinar, attendees will achieve the following program objectives:
1. Identify best practices in collection of non-blood specimens.
2. Review situations resulting in rejection of non-blood specimens.
3. Explain the potential patient impact caused by inadequate specimen collection.
15. March 2018, 13:00, Eastern Daylight Time (New York, GMT-04:00)
Optimising transfection as a starting point for bioproduction
Bioproduction describes the manufacturing process of biological compounds such as recombinant proteins or antibodies. Essential for all subsequent processing steps is the establishment of a well-performing starter culture. An optimised transfection in small scale is one of the first steps to successfully create a stable or transiently protein-producing cell line.
In this webinar, we will give an overview on the bioprocessing workflow with an emphasis on how transfection conditions influence the outcome of protein production.
- Introduction into bioproduction and transient protein production
- Experimental conditions: transfection, protein expression, cell viability, scalability
This webinar will be held on June 02nd, 2016 at 10:00 a.m. and 7.00 p.m. CET.
02. June 2016, 10:00, CET
Dr. Thomas Schreiber, Mathieu Porte